发明名称 |
Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-ILE347 polymorphism |
摘要 |
The present invention is directed to a method identifying a risk for a thrombogenic disorder, to a method for selecting patients with a risk for a thrombogenic disorder, to a method for identifying a pharmaceutical for the therapy or prophylaxis of a thrombogenic disorder as well as to a method for producing a medicament and a diagnostic by employing the TAFI-Ile347 polymorphism.
|
申请公布号 |
US7985562(B2) |
申请公布日期 |
2011.07.26 |
申请号 |
US20090474794 |
申请日期 |
2009.05.29 |
申请人 |
SANOFI-AVENTIS DEUTSCKLAND GMBH |
发明人 |
KOZIAN DETLEF;SCHAEFER STEFAN;SCHOELKENS BERNWARD;SIEGLER KARL-ERNST;DELEUZE JEAN-FRANCOIS;RICARD SYLVAIN;MACE SANDRINE |
分类号 |
G01N33/00;C12N15/14;G01N33/68 |
主分类号 |
G01N33/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|